Replies to post #1829 on Ardelyx Inc (ARDX)

[Whalatane]

Sorry ..yes I saw the report on VRTX ...no position
I'm stunned ARDX sold $25m of Xphozah with no / little access to Medicare ..in Q2 ...90% of the dialysis population is on Medicare .
It makes me want to go very long on UNCY when I see for certain , the road to approval ...as they will have 100% reimbursement on Medicare for at least the first 2 yrs
ARDX's number for Ibsrela were great

Kiwi